メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
臨床薬剤科
藤田医科大学
医学部
概要
フィンガープリント
ネットワーク
プロファイル
(9)
研究成果
(20)
フィンガープリント
臨床薬剤科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Pairwise Meta-analysis
90%
Major Depressive Disorder
73%
Meta-analysis
73%
Newer Antidepressants
68%
Systematic Meta-analysis
68%
Nontuberculous Mycobacterial Lung Disease
68%
Secondary Pulmonary Hypertension
68%
Nontuberculous Mycobacteriosis
68%
Multidisciplinary Cancer Team
68%
Vicarious Experience
68%
Intermittent theta Burst Stimulation (iTBS)
68%
Japanese Adults
68%
Anticholinergic Risk Scale
68%
Age Diversity
68%
Left DLPFC
56%
Confidence Interval
45%
Japanese Patients
45%
Standardized Mean Difference
45%
Diffuse Lung Disease
34%
Ground Grass Opacity
34%
Right Dorsolateral Prefrontal Cortex
34%
Depressive Symptoms
34%
Bacterial Cultivation
27%
Fibrocavitary
27%
Mycobacterium
27%
Residual Lesions
27%
Japan
22%
Antidepressants
22%
Random Effects
22%
Placebo
22%
Appropriate Treatment
22%
Risk Ratio
22%
Mean Risk
22%
Stimulation Protocol
22%
Randomized Placebo-controlled Trial
22%
Symptom Scale
22%
Anticholinergic Burden
20%
Disease Education
17%
Pharmacy Store
17%
Sugi
17%
Memorial Foundation
17%
Health Consultation
17%
Hashima
15%
Tsukuba
15%
Kumada
15%
Fumier
15%
Pharmaceutical Services
15%
Yokohama
15%
Toyota Motor Corporation
15%
Learning Value
13%
Meeting Satisfaction
13%
Conference Room
13%
Ectatic Disorders
13%
Adjuvant Surgery
13%
Specimen Type
13%
M. Gordonae
13%
Chemotherapy Duration
13%
Operation Type
13%
Image Score
13%
Nodular Disease
13%
Discontinuation Rate
11%
Favorable Risk
11%
Occipital Lobe
11%
All-cause Discontinuation
11%
Remission Rate
11%
Risk-benefit Ratio
11%
Headache
11%
Sham
11%
Dorsolateral Prefrontal Cortex (DLPFC)
11%
Mania
11%
Treatment Site
11%
Symptom Improvement
11%
Fukui
7%
Cultural Factors
6%
Cumulative Impacts
6%
Profile Factors
6%
Scale Development
6%
Accelerated Treatment
5%
Response Rate
5%
Therapeutic Modalities
5%
Randomized Controlled Trial
5%
Random Effects Model
5%
Network Meta-analysis
5%
No Significant Difference
5%
Clinical Practice
5%
Depression Treatment
5%
Network Model
5%
Repetitive Transcranial Magnetic Stimulation (rTMS)
5%
Treatment Plan
5%
High Response Rate
5%
Nursing and Health Professions
Confidence Interval
100%
Chronic Kidney Failure
68%
Major Depression
68%
Malignant Neoplasm
68%
Systematic Review
68%
Meta Analysis
68%
Outpatient
68%
Lung Disease
68%
Blood Pressure
68%
Antidepressant
68%
Lumbar Spinal Stenosis
68%
Placebo
45%
Frailty
40%
Glucose Level
34%
Glucose Blood Level
34%
Cardiovascular Disease
34%
Pain Measurement
27%
Polypharmacy
27%
Syndrome
27%
Life Expectancy
27%
Depression
22%
Hospital Organization
17%
Claudication
13%
Nursing Care
9%
Loneliness
9%
Self-Efficacy
9%
Medicine and Dentistry
Antidepressant
68%
Lumbar Spinal Stenosis
68%
Mycobacteriosis
68%
Open Lung Biopsy
68%
Dorsolateral Prefrontal Cortex
68%
Frailty
27%
Walking Ability
27%
Polypharmacy
27%
Pain Measurement
27%
Life Expectancy
27%
Orthopedics
27%
Mycobacteria
22%
Dorsomedial Prefrontal Cortex
22%
Frailty Index
13%
Claudication
13%
Geriatrics
13%
Treatment of Depression
11%
Mycobacterium avium
8%
Mycobacterium gordonae
8%
Mycobacterium Intracellulare
8%